A quantitative approach to segmentation for prescription drug safety programs

Abstract

Purpose The aim of this paper is to enhance the effectiveness of pharmacovigilance programs that provide information about medical products to benefit consumers, aid health care professional’s decision-making and improve community health. This research sought to determine whether distinct segments of consumers can be identified for prescription drug safety social marketing and communication activities and if these segments would respond differently to information about prescription drug products. Design/methodology/approach Theories of risk information-seeking behavior were used to develop questions for respondents in an online survey panel. Latent class analyses identified clusters that were similar in their ability to accurately interpret risks and benefits, preferred sources of health information, medication use and other related factors. Multinomial logistic regression models identified demographic and psychographic differences across the segments. Logistic and linear regression models were then used to compare each segment’s responses to a specific drug safety information product. Findings The 1,244 respondents were clustered into four segments: not engaged (12 per cent), low-involvement users (29 per cent), careful users (50 per cent) and social information seekers (9 per cent). These segments were distinguished by perceived seeking control, self-appraisal of skill, information insufficiency, self-efficacy, information competency and health literacy. Sources of health information and health-seeking behaviors were also different across the four segments. Significant differences were found among the segments in their comprehension and perceived utility of the content and their intentions to take relevant actions. Practical implications From an array of potential behavioral influences, adults can be segmented by risk information-seeking constructs and related behaviors. These segments respond differently to drug safety information. Use of the personas developed in this work can help pharmacovigilance programs around the world develop more relevant and tailored social marketing products, services and content. Originality/value A social marketing approach using empirically tested theoretical constructs can be useful for drug safety or pharmacovigilance programs. The results were used to create personas that quickly convey relevant information to drug safety program managers and staff.

The Vaping Teenager: Understanding the Psychographics and Interests of Adolescent Vape Users to Inform Health Communication Campaigns

“…Audience psychographics move beyond demographics to provide health communicators with critical insights about values, identities, and interests that can inform effective messaging and campaign strategies. 32-35 In addition, these insights are critical for the effective planning and execution of modern digital media campaigns that rely on interest-based targeting to deliver digital advertisements to the intended audience. 36 Past studies describing ever and current vape users have typically focused on vaping attitudes and beliefs, 37-40 or have used psychographics and motivations to segment adult, but not adolescent, vape users into discrete subgroups.…”

The structure of sustainability marketing research: a bibliometric review and directions for future research

“…, 2018). The authors, for example, have studied segmentation for prescription drug safety programs (Lefebvre et al. , 2016).…”

“…Segmentation theory is a useful Marketing research for being sustainable way for targeting social marketing campaigns to match the demands of various subgroups in order to achieve more effective behavior change (Kitunen et al, 2018). The authors, for example, have studied segmentation for prescription drug safety programs (Lefebvre et al, 2016). Studies on green marketing from a macro perspective are included in the topic of "macromarketing."…”

Análise bibliométrica e sistemática das publicações sobre Decisão e Envolvimento com o Produto

“…Armellini e Ford (2017) examinam o benefício do consumidor e a extensão de um vínculo emocional com produtos individualizados e concluíram que a individualização pode oferecer novas experiências aos consumidores passivos, ao gerar um vínculo emocional que resulta numa vida útil mais longa do produto. Lefebvre et al (2016) identificaram segmentos distintos de consumidores para atividades de marketing social e comunicação sobre segurança de medicamentos controlados, sendo os participantes agrupados em: não envolvidos, usuários de baixo envolvimento, usuários cuidadosos e buscadores de informações sociais.…”